The impact of prothrombotic mutations, PSGL-1 VNTR polymorphism, tissue factor, and soluble P-selectin on venous thromboembolism in cancer patients with adenocarcinoma

Abstract

50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, MAY 30-JUN 03, 2014